National Institute on Aging; Notice of Closed Meeting, 71910-71911 [2024-19753]
Download as PDF
<![CDATA[
71910
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 / Notices
Dated: August 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–19815 Filed 9–3–24; 8:45 am]
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK RC2 Review.
Date: November 19, 2024.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, NIDDK
Democracy II, Suite 7000A, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ann A. Jerkins, Ph.D.,
Scientific Review Officer, National Institute
of Diabetes and Digestive and Kidney,
National Institute of Health, 6707 Democracy
Boulevard, Rm 7119, Bethesda, MD 20892–
5452, 301–594–2242, jerkinsa@
niddk.nih.gov.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic
Research; 93.848, Digestive Diseases and
Nutrition Research; 93.849, Kidney
Diseases, Urology and Hematology
Research, National Institutes of Health,
HHS)
Dated: August 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–19752 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
21:26 Sep 03, 2024
Jkt 262001
National Institutes of Health
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; NCCIH Training and
Education Review Panel (CT).
Date: October 31–November 1, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Michael E. Authement,
Ph.D., Scientific Review Officer, Office of
Scientific Review, Division of Extramural
Activities, 6707 Democracy Boulevard,
Bethesda, MD 20817, michael.authement@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: August 28, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–19817 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; NSF Program—EDGE Research.
Date: September 27, 2024.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892 (Video
Assisted Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, MSC 6908, Bethesda, MD
20892, (301) 42–8739, pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: August 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2024–19746 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel Pathobiology
of AD.
Date: October 24, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\04SEN1.SGM
04SEN1
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 / Notices
Place: National Institute on Aging, 5601
Fishers Lane Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Mariel Jais, PharmD,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, Room 2E400, Rockville, MD
20852, (301) 594–2614, mariel.jais@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–19753 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Leveraging Data at
Scale to Understand Natural Product Impacts
on Whole Person Health (R01 Clinical Trial
Not Allowed).
Date: October 24, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Limited
Competition: Research Resource for Natural
Product Nuclear Magnetic Resonance Data
(R24 Clinical Trial Not Allowed).
Date: October 24, 2024.
Time: 10:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
21:26 Sep 03, 2024
Jkt 262001
71911
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Botanical Dietary
Supplements Translational Research Teams
(RM1 Clinical Trial Required).
Date: October 24–25, 2024.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: August 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: August 28, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–11:
NCI Clinical and Translational Cancer
Research.
Date: October 2, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W608, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches.
Date: October 2, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W526, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Viktoriya Sidorenko,
Ph.D., Scientific Review Officer, Program and
Review Extramural Staff Training Office,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W526, Rockville, Maryland
20850, 240–276–5073, viktoriya.sidorenko@
nih.gov.
[FR Doc. 2024–19814 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Center for
Advancing Translational Sciences
Special Emphasis Panel, from November
6, 2024, 9:30 a.m. to November 7, 2024,
1:00 p.m., National Institutes of Health,
9609 Medical Center Drive, Rockville,
MD, 20850 which was published in the
Federal Register on August 20, 2024, 89
FR 67456.
The meeting dates and times is being
changed due to the availability of
members with required expertise; start
date & time will change from 11/06/24
9:30 a.m. to 10/29/24 10:00 a.m.; end
date & time will change from 11/07/24
1:00 p.m. to 10/30/24 2:00 p.m. The
meeting is closed to the public.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
[FR Doc. 2024–19740 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 89, Number 171 (Wednesday, September 4, 2024)]
[Notices]
[Pages 71910-71911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel Pathobiology of AD.
Date: October 24, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
[[Page 71911]]
Place: National Institute on Aging, 5601 Fishers Lane Rockville,
MD 20892 (Virtual Meeting).
Contact Person: Mariel Jais, PharmD, Scientific Review Officer,
National Institute of Aging, National Institute of Health, 5601
Fishers Lane, Room 2E400, Rockville, MD 20852, (301) 594-2614,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: August 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-19753 Filed 9-3-24; 8:45 am]
BILLING CODE 4140-01-P
